Drug Information

Drug General Information
Drug ID
D0F3ZO
Former ID
DNC003601
Drug Name
2-(phosphonomethyl)pentanedioic acid
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529200]
Formula
C6H11O7P
Canonical SMILES
C(CC(=O)O)C(CP(=O)(O)O)C(=O)O
InChI
1S/C6H11O7P/c7-5(8)2-1-4(6(9)10)3-14(11,12)13/h4H,1-3H2,(H,7,8)(H,9,10)(H2,11,12,13)
InChIKey
ISEYJGQFXSTPMQ-UHFFFAOYSA-N
PubChem Compound ID
10130754
Target and Pathway
Target(s) Glutamate carboxypeptidase II Target Info Inhibitor [529200]
KEGG Pathway Alanine, aspartate and glutamate metabolism
Metabolic pathways
Vitamin digestion and absorption
NetPath Pathway TCR Signaling Pathway
TNFalpha Signaling Pathway
Reactome Amino acid synthesis and interconversion (transamination)
WikiPathways One Carbon Metabolism
References
Ref 529200Bioorg Med Chem. 2008 Feb 15;16(4):1648-57. Epub 2007 Nov 17.Design and synthesis of a siderophore conjugate as a potent PSMA inhibitor and potential diagnostic agent for prostate cancer.
Ref 529200Bioorg Med Chem. 2008 Feb 15;16(4):1648-57. Epub 2007 Nov 17.Design and synthesis of a siderophore conjugate as a potent PSMA inhibitor and potential diagnostic agent for prostate cancer.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.